Equillium (EQ) Research & Development (2018 - 2026)

Equillium (EQ) has reported Research & Development for 9 consecutive years, with $3.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Research & Development fell 49.51% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $14.5 million (down 56.76% YoY), while the FY2025 annual figure was $12.8 million, down 65.69% from the prior year.
• Research & Development advanced to $3.0 million in Q1 2026 per EQ's latest filing, from $1.5 million in the prior quarter.
• Across five years, Research & Development topped out at $10.8 million in Q2 2024 and bottomed at $400000.0 in Q3 2025.
• Historically, Research & Development has averaged $7.5 million across 5 years, with a median of $9.0 million in 2023.
• Annual changes were most pronounced in 2022 — Research & Development soared 83.04% — and 2025, when it plunged 95.82%.
• Equillium's Research & Development stood at $8.5 million in 2022, then grew by 7.73% to $9.2 million in 2023, then decreased by 20.35% to $7.3 million in 2024, then tumbled by 79.0% to $1.5 million in 2025, then surged by 94.73% to $3.0 million in 2026.
• Business Quant data shows EQ's Research & Development at $3.0 million in Q1 2026, $1.5 million in Q4 2025, and $400000.0 in Q3 2025.